MicroRNA expression profiling of human blood monocyte subsets highlights functional differences

Immunology

Volumn 145, Issue 3, 2015, Pages 404-416

  Dang, Truong Minh ^a   Wong, Wing Cheong ^b   Ong, Siew Min ^a   Li, Peng ^a   Lum, Josephine ^a   Chen, Jinmiao ^a   Poidinger, Michael ^a   Zolezzi, Francesca ^a   Wong, Siew Cheng ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b BIOINFORMATICS INSTITUTE   (Singapore)

Author keywords

Apoptosis; MicroRNA; Migration; Monocyte subset

Indexed keywords

CD16 ANTIGEN; MICRORNA; MICRORNA 1275; MICRORNA 132; MICRORNA 146A; MICRORNA 1537; MICRORNA 18A; MICRORNA 18B; MICRORNA 19; MICRORNA 202; MICRORNA 20B; MICRORNA 221; MICRORNA 27A; MICRORNA 29A; MICRORNA 29B; MICRORNA 29C; MICRORNA 345; MICRORNA 34A; MICRORNA 370; MICRORNA 432; MICRORNA 452; MICRORNA 493; MICRORNA 494; MICRORNA 495; MICRORNA 513B; MICRORNA 517C; MICRORNA 556 3P; MICRORNA 637; MICRORNA 656; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; FC RECEPTOR; MIRN19 MICRORNA, HUMAN; MIRN345 MICRORNA, HUMAN; MIRN432 MICRORNA, HUMAN; RELA PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE ONTOLOGY; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INFLAMMATION; MEDIATOR RELEASE; MICROARRAY ANALYSIS; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; 3' UNTRANSLATED REGION; CELL CULTURE; CELL MOTION; CLASSIFICATION; DNA MICROARRAY; GENETICS; HEK293 CELL LINE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3' UNTRANSLATED REGIONS; APOPTOSIS; CELL MOVEMENT; CELLS, CULTURED; GENE EXPRESSION PROFILING; HEK293 CELLS; HUMANS; MICRORNAS; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, IGG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR RELA;

EID: 84931430165     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12456     Document Type: Article

References (78)

1. Passlick B, Flieger D, Ziegler-Heitbrock HW. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989; 74:2527-34.
2. + blood monocytes is expanded in sepsis patients. Blood 1993; 82:3170-6.
3. high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 1995; 25:3418-24.
4. + blood monocytes in patients with active Crohn's disease. Inflamm Bowel Dis 2007; 13:566-72.
5. + blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 2002; 46:2578-86.
6. ++ monocytes are a major source of TNF. J Immunol 2002; 168:3536-42.
7. Frankenberger M, Sternsdorf T, Pechumer H, Pforte A, Ziegler-Heitbrock HW. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 1996; 87:373-7.
8. Zhao C, et al. Identification of novel functional differences in monocyte subsets using proteomic and transcriptomic methods. J Proteome Res 2009; 8:4028-38.
9. + blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007; 81:584-92.
10. +) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med 2002; 196:517-27.
11. dim Monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2009; 33:375-86.
12. Frankenberger MM, et al. Transcript profiling of CD16-positive monocytes reveals a unique molecular fingerprint. Eur J Immunol 2012; 42:957-74.
13. Ingersoll MA, et al. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 2010; 115:e10-9.
14. - monocyte subsets. BMC Genom 2009; 10:403.
15. - subset. Cell Death Dis 2010; 1:e95.
16. Larsson O, Nadon R. Re-analysis of genome wide data on mammalian microRNA-mediated suppression of gene expression. Translation 2013; 1:e24557.
17. Rajewsky N. microRNA target predictions in animals. Nat Genet 2006; 38(Suppl.):S8-13.
18. Bidzhekov KK, et al. microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans. Thromb Haemost 2012; 107:619-25.
19. Tserel LL, et al. MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor 4. J Biol Chem 2011; 286:26487-95.
20. Li L-M, et al. Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes. J Immunol 2011; 186:2552-60.
21. O'Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol 2012; 30:295-312.
22. Nahid MA, Pauley KM, Satoh M, Chan EKL. miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity. J Biol Chem 2009; 284:34590-9.
23. Bazzoni F, et al. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci USA 2009; 106:5282-7.
24. Bala S, et al. Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. J Transl Med 2012; 10:151.
25. + neonatal monocytes via post-transcriptional regulation. J Leukoc Biol 2012; 92:171-82.
26. Aoki T, et al. Expression profiling of genes related to asthma exacerbations. Clin Exp Allergy 2009; 39:213-21.
27. Wong W-C, Loh M, Eisenhaber F. On the necessity of different statistical treatment for Illumina BeadChip and Affymetrix GeneChip data and its significance for biological interpretation. Biol Direct 2008; 3:23.
28. Grady WM, et al. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 2008; 27:3880-8.
29. He Y-J, et al. miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer. Exp Ther Med 2013; 5:813-8.
30. Cittelly DM, et al. Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. Mol Cancer 2010; 9:317.
31. Arora S, Rana R, Chhabra A, Jaiswal A, Rani V. miRNA-transcription factor interactions: a combinatorial regulation of gene expression. Mol Genet Genomics 2013; 288:77-87.
32. Levy D, et al. Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling. Nat Immunol 2011; 12:29-36.
33. Yang J, et al. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFκB. Genes Dev 2007; 21:1396-408.
34. Catz SD, Babior BM, Johnson JL. JFC1 is transcriptionally activated by nuclear factor-κB and up-regulated by tumour necrosis factor α in prostate carcinoma cells. Biochem J 2002; 367:791-9.
35. Chien Y, et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev 2011; 25:2125-36.
36. Ghosh SS, May MJM, Kopp EBE. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Immunology 1997; 16:225-60.
37. Etzrodt M, et al. Regulation of monocyte functional heterogeneity by miR-146a and Relb. Cell Rep 2012; 1:317-24.
38. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007; 318:1931-4.
39. Lin X, et al. miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation. Leukemia 2013; 27:344-52.
40. Hashimi ST, et al. MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 2009; 114:404-14.
41. Krutzik SR, et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med 2005; 11:653-60.
42. Kloosterman WP, Plasterk RHA. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11:441-50.
43. Ismail N, et al. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood 2013; 121:984-95.
44. Liu D, Yang X, Songyang Z. Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival. Curr Biol 2000; 10:1233-6.
45. Zhou P, Qian L, Kozopas KM, Craig RW. Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 1997; 89:630-43.
46. Reynolds JE, et al. Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 1994; 54:6348-52.
47. Fukazawa R, et al. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. J Mol Cell Cardiol 2003; 35:1473-9.
48. Ryu J, et al. Neuregulin-1 exerts protective effects against neurotoxicities induced by C-terminal fragments of APP via ErbB4 receptor. J Pharmacol Sci 2012; 119:73-81.
49. Yang X, et al. Proprotein convertase furin regulates apoptosis and proliferation of granulosa cells in the rat ovary. PLoS ONE 2013; 8:e50479.
50. -/- mice. Nat Genet 2003; 35:331-40.
51. Takeda N, et al. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1. Circ Res 2004; 95:146-53.
52. Mardilovich K, Shaw LM. Hypoxia regulates insulin receptor substrate-2 expression to promote breast carcinoma cell survival and invasion. Cancer Res 2009; 69:8894-901.
53. Jakubzick C, et al. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity 2013; 39:599-610.
54. Shan SW, et al. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat Cell Biol 2009; 11:1031-8.
55. Nilsson S, et al. Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration. PLoS ONE 2012; 7:e36051.
56. Kang H-W, et al. miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells. FEBS Lett 2012; 586:897-904.
57. Ma Y, et al. Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130. Nat Commun 2012; 3:1291.
58. Iaconetti CC, et al. Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury. Basic Res Cardiol 2012; 107:296.
59. Chen F, et al. RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma. PLoS ONE 2013; 8:e56241.
60. Estecha A, Aguilera-Montilla N, Sánchez-Mateos P, Puig-Kröger A. RUNX3 regulates intercellular adhesion molecule 3 (ICAM-3) expression during macrophage differentiation and monocyte extravasation. PLoS ONE 2012; 7:e33313.
61. Chandhoke SK, Mooseker MS. A role for myosin IXb, a motor-RhoGAP chimera, in epithelial wound healing and tight junction regulation. Mol Biol Cell 2012; 23:2468-80.
62. Thompson TG, et al. Filamin 2 (FLN2): a muscle-specific sarcoglycan interacting protein. J Cell Biol 2000; 148:115-26.
63. Parisiadou L, Cai H. LRRK2 function on actin and microtubule dynamics in Parkinson disease. Commun Integr Biol 2010; 3:396-400.
64. Häbig K, et al. LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4. Biochim Biophys Acta 2013; 1832:2352-67.
65. Thévenet J, Gobert RP, van Huijsduijnen RH, Wiessner C, Sagot YJ. Regulation of LRRK2 expression points to a functional role in human monocyte maturation. PLoS ONE 2010; 6:e21519.
66. Imhof BA, Aurrand-Lions M. Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol 2004; 4:432-44.
67. Shang XZ, Lang BJ, Issekutz AC. Adhesion molecule mechanisms mediating monocyte migration through synovial fibroblast and endothelium barriers: role for CD11/CD18, very late antigen-4 (CD49d/CD29), very late antigen-5 (CD49e/CD29), and vascular cell adhesion molecule-1 (CD106). J Immunol 1998; 160:467-74.
68. Rosseau S, et al. Monocyte migration through the alveolar epithelial barrier: adhesion molecule mechanisms and impact of chemokines. J Immunol 2000; 164:427-35.
69. Perri SR, Annabi B, Galipeau J. Angiostatin inhibits monocyte/macrophage migration via disruption of actin cytoskeleton. FASEB J 2007; 21:3928-36.
70. Konakahara S, et al. A neuronal transmembrane protein LRFN4 induces monocyte/macrophage migration via actin cytoskeleton reorganization. FEBS Lett 2011; 585:2377-84.
71. Hu Y, Hu X, Boumsell L, Ivashkiv LB. IFN-γ and STAT1 arrest monocyte migration and modulate RAC/CDC42 pathways. J Immunol 2008; 180:8057-65.
72. Lei ZZ, et al. Regulation of HIF-1α and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS ONE 2008; 4:e7629.
73. Cascio S, et al. miR-20b modulates VEGF expression by targeting HIF-1α and STAT3 in MCF-7 breast cancer cells. J Cell Physiol 2010; 224:242-9.
74. Lee JS, et al. Hypoxia-induced methylation of a pontin chromatin remodeling factor. Proc Natl Acad Sci USA 2011; 108:13510-5.
75. Gabunia K, et al. Interleukin-19 (IL-19) induces heme oxygenase-1 (HO-1) expression and decreases reactive oxygen species in human vascular smooth muscle cells. J Biol Chem 2012; 287:2477-84.
76. Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 2004; 172:567-76.
77. Conti L, et al. Induction of relA(p65) and IκBα subunit expression during differentiation of human peripheral blood monocytes to macrophages. Cell Growth Differ 1997; 8:435-42.
78. + blood monocytes exhibits features of tissue macrophages. Eur J Immunol 1993; 23:2053-8.